Skip to content

Study on the academic origins of Zhongjing's fever and the treatment of pediatric fever by Dingying

Study on the academic origins of Zhongjing's fever and the treatment of pediatric fever by Dingying

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001125
Enrollment
Unknown
Registered
2025-06-06
Start date
2024-01-08
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious Mononucleosis in children

Interventions

Test group:Ganciclovir intravenous drip therapy combined with Chinese traditional medicine(Ding shi san yang tou jie decoction)
Control group:Ganciclovir intravenous drip

Sponsors

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: (1) Meets the western clinical diagnostic criteria or laboratory confirmation criteria for IM in children; (2) The TCM diagnosis is sanyangrechi syndrome; (3) The age of the child is 1 to 14 years old; (4) Parents of the child signed an informed consent form and were able to adhere to medication and regular follow-up appointments; (5)No serious cardiac cerebral renal circulatory or neurological damage and able to adhere to the medication and regular follow-up.

Exclusion criteria

Exclusion criteria: (1) Contraindications to ganciclovir administration or hypersensitivity to known constituents of herbal preparations; (2) Serious complications during the course of the disease such as phagocytic syndrome splenic rupture and meningitis; (3) Having been treated with antiviral drugs or other herbal formulas within one week prior to treatment; (4) Those who cannot use the medication as prescribed or have incomplete information etc. which affects the judgment of efficacy and safety.

Design outcomes

Primary

MeasureTime frame
Time to complete antipyretic;Disease Efficacy;

Secondary

MeasureTime frame
Proportion of heterogeneous lymphocytes;Peripheral blood lymphocyte ratio;T-lymphocyte subset;Scoring of major clinical symptoms and signs;EBV-DNA load;Chinese Medicine Symptoms;

Countries

china

Contacts

Public ContactYongbin YAN

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

yanyongbin827@sina.com+86 155 1573 0918

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026